Searchable abstracts of presentations at key conferences in endocrinology

ea0049s30.2 | Moving away from old-fashioned steroidogenesis: what are the clinical implications? | ECE2017

Clinical relevance of steroid precursors in adrenocortical tumors

Chortis Vasileios

Adrenal incidentalomas represent an increasingly common diagnostic problem facing clinical Endocrinologists. Swift and accurate differentiation of benign from malignant disease is essential, but the diagnostic performance of current imaging modalities is sub-optimal and often leads to ill-advised management decisions. Urinary steroid profiling by modern mass spectrometry-based techniques can provide a comprehensive profile of steroidogenesis, quantifying both precursor molecul...

ea0062p43 | Poster Presentations | EU2019

Thyroid storm - from clinic to intensive care

Chortis Vasileios , Hazlehurst Jonathan , Boelaert Kristien

Case history: A 46-year-old female patient presented to A&E with a three day history of diarrhoea and vomiting, after three months of progressive weight loss. Her past medical history included chronic autoimmune thrombocytopaenia and Graves’ disease, which had been diagnosed four years earlier and treated with a brief course of propylthyuracil (PTU). She was clinically in extremis, with signs of severe cardiovascular and respiratory compromise and reduced res...

ea0034p138 | Clinical practice/governance and case reports | SFEBES2014

Acute confusional state in the thyroid clinic: autoimmunity as a multi-edge knife

Chortis Vasileios , Edmunds Matthew , Littleton Edward , Boelaert Kristien

A 67-year-old lady with a 3-year history of Graves’ hyperthyroidism complicated by florid Graves’ ophthalmopathy attended the thyroid clinic at University Hospital Birmingham for routine follow up. Her thyrotoxicosis had been managed with long-term carbimazole treatment with good control. Her past medical history included coeliac disease and hypertension. On clinic review, she appeared acutely confused and disorientated and had evidently lost weight. Her family repor...

ea0034p139 | Clinical practice/governance and case reports | SFEBES2014

Jumping the gun: an audit of adrenal biopsies in a tertiary referral centre

Chortis Vasileios , Scordilis Kassiani , Arlt Wiebke , Crowley Rachel

New adrenal lesions discovered during cross-sectional abdominal imaging pose an increasingly common diagnostic challenge; their initial management should focus on the exclusion of malignancy and autonomous hormone excess. The role of adrenal biopsies in this context is limited and pathologists often struggle to differentiate benign from malignant adrenal tissue even when analysing the entire tumour specimen. Guidelines recommend that adrenal biopsy should only be considered if...

ea0041oc9.3 | Endocrine Tumours | ECE2016

Stressed to death – antioxidant pathway targeting as a novel therapeutic approach in adrenocortical carcinoma

Chortis Vasileios , Taylor Angela E , Doig Craig L , Meimaridou Eirini , Metherell Louise A , Arlt Wiebke , Foster Paul A

Context: Nicotinamide nucleotide transhydrogenase (NNT) is a NADPH-generating mitochondrial proton pump with a central role in mitochondrial antioxidant pathways. Recent studies revealed inactivating NNT mutations in patients with familial glucocorticoid deficiency, indicating a selective susceptibility of the adrenal cortex to NNT deficiency and oxidative stress. Here we explored the potential value of NNT as a therapeutic target in adrenocortical cancer.<p class="abstext...

ea0038oc1.3 | Early Career Oral Communications | SFEBES2015

RNA-sequencing of mouse adrenals reveals the pathways perturbed by loss of nicotinamide nucleotide transhydrogenase

Meimaridou Eirini , Goldsworthy Michelle , Chortis Vasileios , Foster Paul , Arlt Wiebke , Cox Roger , Metherell Lou

Nicotinamide nucleotide transhydrogenase (NNT) is a highly conserved inner mitochondrial membrane protein, which supplies high concentrations of NADPH for detoxification of reactive oxygen species (ROS) by glutathione and thioredoxin pathways. In humans, loss-of-function mutations in NNT cause familial glucocorticoid deficiency, a potentially fatal, adrenal specific disorder characterized by increased levels of ACTH and low levels of cortisol. Nnt−...

ea0038p145 | Neoplasia, cancer and late effects | SFEBES2015

Nicotinamide nucleotide transhydrogenase (NNT) as a novel molecular target in adrenocortical carcinoma – impact of NNT knockdown on adrenocortical cell proliferation, redox balance and steroidogenesis

Chortis Vasileios , Taylor Angela , Doig Craig , Meimaridou Eirini , Metherell Lou , Arlt Wiebke , Foster Paul

Nicotinamide nucleotide transhydrogenase (NNT) is a NADPH-generating mitochondrial proton pump with a central role in mitochondrial antioxidant pathways. Recent studies revealed inactivating NNT mutations in patients with familial glucocorticoid deficiency, indicating a selective susceptibility of the adrenal cortex to NNT deficiency and oxidative stress. Here we explored the potential value of NNT as a therapeutic target in adrenocortical cancer. We delineated the distinct ef...

ea0037ep1145 | Endocrine tumours | ECE2015

Mitotane treatment for metastatic Leydig cell tumour

Chortis Vasileios , Johal Nicholas , Cullen Michael , Bancos Irina , Guest Peter , Porfiri Emilio , Arlt Wiebke

Introduction: Testicular leydig cell tumours (LCTs) are rare stromal tumors often associated with androgen excess. Metastatic malignant LCTs typically show resistance to radiotherapy and cytotoxic chemotherapy, calling for alternative management options. Here we describe our experience with treatment of two patients with metastatic LCTs with the adrenolytic drug Mitotane.Patients/methods: Case 1: A 51-year-old patient presented with a 6 month hi...

ea0034p126 | Clinical practice/governance and case reports | SFEBES2014

Double trouble: pseudo-phaeochromocytoma in a patient with adrenocortical cancer

May Christine , Jahagirdar Vidhya , Chortis Vasileios , Jenkins David , Arlt Wiebke , Ayuk John

A 34-year-old male with no significant past medical history presented with severe abdominal pain. On detailed questioning his symptoms included tremors, headache, sweating, and agitation. Despite recent weight gain he had obvious muscle wasting. On admission blood pressure was 166/107 mmHg. Abdominal examination revealed a palpable left upper quadrant mass.CT scan demonstrated a 15 cm mass in the left supernal region with extensive signs of haemorrhage i...

ea0065p134 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer | SFEBES2019

PLK1 inhibitors as potential new treatment for adrenocortical carcinoma

Smith Gabrielle , Liang Raimunde , Chortis Vasileios , Lippert Juliane , Hantel Constanze , Altieri Barbara , Fassnacht Martin , Foster Paul , Ronchi Cristina

Background: Adrenocortical carcinoma (ACC) is a rare aggressive cancer with limited treatment options for advanced stages. By targeted RNA expression screening, we identified polo-like kinase 1 (PLK1) as one of most overexpressed genes, thus representing a potential drug target for ACC. PLK1 inhibitors are under evaluation in clinical trials for other solid cancers and seem to be more effective in TP53 mutated tumours. The aim of the study was to evaluate PLK1 protein levels i...